Prenylamine
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C24H27N |
| Molar mass | 329.48 g/mol |
|
WikiDoc Resources for Prenylamine |
|
Articles |
|---|
|
Most recent articles on Prenylamine Most cited articles on Prenylamine |
|
Media |
|
Powerpoint slides on Prenylamine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Prenylamine at Clinical Trials.gov Clinical Trials on Prenylamine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Prenylamine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Prenylamine Discussion groups on Prenylamine Patient Handouts on Prenylamine Directions to Hospitals Treating Prenylamine Risk calculators and risk factors for Prenylamine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Prenylamine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Prenylamine (Segontin) is a calcium channel blocker of the amphetamine chemical class which is used as a vasodilator in the treatment of angina pectoris. It has been shown to partially metabolize to amphetamine and can cause false positives for it in drug tests.[1][2][3] Prenylamine also appears to act as a vesicular monoamine transporter inhibitor, and has been demonstrated to deplete vesicular monoamine neurotransmitter stores similarly to reserpine.[4]
References
- ↑ Kraemer T, Roditis SK, Peters FT, Maurer HH (March 2003). "Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS". Journal of Analytical Toxicology. 27 (2): 68–73. doi:10.1093/jat/27.2.68. PMID 12669999.
- ↑ Musshoff F (February 2000). "Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine". Drug Metabolism Reviews. 32 (1): 15–44. doi:10.1081/DMR-100100562. PMID 10711406.
- ↑ Cody JT (May 2002). "Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results". Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 44 (5): 435–50. doi:10.1097/00043764-200205000-00012. PMID 12024689.
- ↑ Bagchi SP (1990). "Antidopaminergic action of verapamil and several other drugs: inactivation of vesicular dopamine". Life Sciences. 46 (12): 857–63. doi:10.1016/0024-3205(90)90115-8. PMID 1969603.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Pages using duplicate arguments in template calls
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Vasodilators
- Cardiovascular Drugs
- Drug